BioNTech SE ADR

BNTX: XNAS (USA)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
pLxLOCK|b!DLOCK|!^n%cbg

Bristol-Myers and BioNTech: Oncology Collaboration Further Solidifies BNT327's Potential

Bristol-Myers Squibb and BioNTech have entered a collaboration to co-develop and commercialize BioNTech's BNT327, a clinical-stage PD-L1/VEGF-A bispecific antibody for treating cancer.

Sponsor Center